Sentinel lymph node biopsy may reduce the need for axillary dissection in cN1 breast cancer
1. Upfront sentinel lymph node biopsy permitted the avoidance of axillary lymph node dissection in most patients with cN1 HR+/HER2- ...
Tag: HER2-negative
Imlunestrant extends progression-free survival in ER-positive, HER2-negative breast cancer
1. In this randomized controlled trial, in patients with estrogen receptor (ER)-positive, human epidermal growth factor receptor 2 (HER2)-negative advanced ...
